Semnur Pharmaceuticals Inc.

Semnur Pharmaceuticals Inc.

OOTC:SMNR
0.50
USD
+0.12
(+32.98%)
-0.75EPS
115.10MMarket Cap

Income Statement (USD)

2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
4
3
5
160
+ Selling, General & Admin
2
2
3
158
+ Research & Development
2
2
2
3
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-4
-3
-5
-160
- Non-Operating (Income) Loss
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
Pretax Income
-4
-3
-5
-160
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-4
-3
-5
-160
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-4
-3
-5
-160
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-4
-3
-5
-160
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-4
-3
-5
-160
EBIT
-4
-3
5
160
EBITDA
-4
-3
5
160
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
- -
- -
- -
- -
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
200
200
200
205
Basic EPS, GAAP
-0.02
-0.02
-0.02
-0.78
Basic EPS from Cont Ops
-0.02
-0.02
-0.02
-0.78
Diluted Weighted Avg Shares
200
200
200
205
Diluted EPS, GAAP
-0.02
-0.02
-0.02
-0.78
Diluted EPS from Cont Ops
-0.02
-0.02
-0.02
-0.78

Balance Sheet (USD)

2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
- -
6
1
+ Cash, Cash Equivalents & STI
- -
- -
- -
- -
+ Cash & Cash Equivalents
- -
- -
- -
- -
+ ST Investments
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
- -
6
1
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
1
1
1
1
+ Property, Plant & Equip, Net
1
1
1
1
+ Property, Plant & Equip
1
1
1
1
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
1
1
7
1
+ Payables & Accruals
- -
1
- -
6
+ Accounts Payable
- -
- -
- -
6
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
- -
- -
+ ST Debt
- -
- -
- -
4
+ ST Borrowings
- -
- -
- -
4
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
Total Current Liabilities
- -
1
- -
10
+ LT Debt
35
38
49
12
+ LT Borrowings
35
38
49
12
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
Total Noncurrent Liabilities
35
38
49
12
Total Liabilities
36
39
49
22
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
73
73
73
255
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
73
73
73
255
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-107
-111
-115
-276
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-35
-38
-43
-21
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-35
-38
-43
-21
Total Liabilities & Equity
1
1
7
1
Shares Outstanding
240
240
240
230
Number of Employees
1
1
2
3
Capital Leases - Total
- -
- -
- -
- -
Net Debt
35
38
49
15
Net Debt to Equity
-101.55
-99.46
-115.51
-74.34
Tangible Common Equity Ratio
-4,571.26
-5,418.78
-640.1
-1,541.68
Current Ratio
0.37
0.02
171.29
0.06
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-4
-3
-5
-160
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
1
1
1
142
+ Stock-Based Compensation
1
1
1
142
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
-1
1
-1
12
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
-1
+ Inc (Dec) in Accts Payable
-1
1
-1
3
+ Inc (Dec) in Other
- -
- -
- -
10
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-4
-2
-5
-6
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
4
2
5
6
+ Cash From Debt
4
2
5
6
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
4
2
5
6
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
- -
- -
- -
- -
EBITDA
-4
-3
5
160
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-4
-2
-5
-6
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
- -
- -
Free Cash Flow per Basic Share
-0.02
-0.01
-0.02
-0.03
Price/Free Cash Flow
- -
- -
- -
-523.57
Cash Flow to Net Income
1.07
0.51
1.04
0.04
Capital Expenditures
- -
- -
- -
- -